ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,247, issued on May 13, was assigned to NantCell Inc. (Culver City, Calif.).
"Fusion molecules of CTLA4 and IL-15" was invented by Clifford Anders Olson (Long Beach, Calif.), Patrick Soon-Shiong (Los Angeles) and Shiho Tanaka (Redondo Beach, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Soluble fusion protein complexes, including domains from IL-15, IL-15 receptor, and AlphaCTLA4 antibody for preventing, reducing the occurrence of, and/or treating cancer or an autoimmune disease or disorder in a subject are provided herein. The methods provided herein include administering to a subject a pharmaceutical composition of a soluble fusion protein ...